|
HY-P9968-1mg
|
MedChemexpress LLC
|
Nimotuzumab [CAS 780758-10-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-P9968-5mg
|
MedChemexpress LLC
|
Nimotuzumab [CAS 780758-10-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-P99756-1mg
|
MedChemexpress LLC
|
Nirsevimab [CAS 1989556-22-0]
|
|
COVID-19-anti-virus
|
|
|
HY-P99756-10mg
|
MedChemexpress LLC
|
Nirsevimab [CAS 1989556-22-0]
|
|
COVID-19-anti-virus
|
|
|
HY-P99756-5mg
|
MedChemexpress LLC
|
Nirsevimab [CAS 1989556-22-0]
|
|
COVID-19-anti-virus
|
|
|
HY-P99763-1mg
|
MedChemexpress LLC
|
Ociperlimab [CAS 2342597-93-5]
|
|
|
|
|
HY-P99763-10mg
|
MedChemexpress LLC
|
Ociperlimab [CAS 2342597-93-5]
|
|
|
|
|
HY-P99763-5mg
|
MedChemexpress LLC
|
Ociperlimab [CAS 2342597-93-5]
|
|
|
|
|
HY-P99764-1mg
|
MedChemexpress LLC
|
Odesivimab [CAS 2135632-30-1]
|
|
|
|
|
HY-P99764-10mg
|
MedChemexpress LLC
|
Odesivimab [CAS 2135632-30-1]
|
|
|
|
|
HY-P99764-5mg
|
MedChemexpress LLC
|
Odesivimab [CAS 2135632-30-1]
|
|
|
|
|
HY-P99768-1mg
|
MedChemexpress LLC
|
Olinvacimab [CAS 2095504-49-5]
|
|
|
|
|
HY-P99768-10mg
|
MedChemexpress LLC
|
Olinvacimab [CAS 2095504-49-5]
|
|
|
|
|
HY-P99768-5mg
|
MedChemexpress LLC
|
Olinvacimab [CAS 2095504-49-5]
|
|
|
|
|
HY-P9950-1mg
|
MedChemexpress LLC
|
Omalizumab [CAS 242138-07-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-P9950-5mg
|
MedChemexpress LLC
|
Omalizumab [CAS 242138-07-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99770-1mg
|
MedChemexpress LLC
|
Omodenbamab [CAS 2241724-48-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99770-10mg
|
MedChemexpress LLC
|
Omodenbamab [CAS 2241724-48-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99770-5mg
|
MedChemexpress LLC
|
Omodenbamab [CAS 2241724-48-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99794-1mg
|
MedChemexpress LLC
|
Osocimab [CAS 2056878-75-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P99794-10mg
|
MedChemexpress LLC
|
Osocimab [CAS 2056878-75-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P99794-5mg
|
MedChemexpress LLC
|
Osocimab [CAS 2056878-75-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P99406-1mg
|
MedChemexpress LLC
|
Petosemtamab [CAS 2213450-26-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-P99406-10mg
|
MedChemexpress LLC
|
Petosemtamab [CAS 2213450-26-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-P99406-5mg
|
MedChemexpress LLC
|
Petosemtamab [CAS 2213450-26-9]
|
|
Cancer-Kinase/protease
|
|
